Nearly 90 percent of physicians perceived generic medications as effective and 91 percent perceived them to be as safe as their branded counterparts, according to a survey of American Board of Internal Medicine-certified doctors.

Researchers have captured video showing microtubules in the heart serve as molecular shock absorbers, Science reports. 

The FDA approved the CardioMEMS system in 2014, three years after an FDA panel voted against the device’s approval. Since then, two trials have estimated the cost-effectiveness of the system, which is indicated to monitor patients with heart failure. Two prominent cardiologists, however, argue that determining whether the CardioMEMS is effective is of more pressing concern than figuring out if it’s cost-effective.

Glen Nelson, MD, a surgeon and former Medtronic executive, died on May 14, the Minneapolis Star Tribune reported.

The Association of Black Cardiologists (ABC) elected Felix Sogade, MD, as chairman of its board of directors and Barbara Hutchinson, MD, PhD as the organization’s president.

The Duke Clinical Research Institute and SAS announced that they would provide researchers with cardiovascular patient data that the Duke University Health System collected during a 45-year period.

Alfred Spivack, MD, a cardiologist and clinical professor emeritus of medicine at Stanford University, died on April 23. He was 87.

Valeant testified in front of Congress on May 4 and said it would offer hospitals as much as a 30 percent discount on nitropress and isuprel, two commonly prescribed medications for heart patients.